Data gathered: February 1
AI Stock Analysis - Embecta (EMBC)
Analysis generated May 10, 2024. Powered by Chat GPT.
Embecta, presumably a company in the healthcare sector, has established itself in the market with a focus on delivering substantial value to its customer base. The company operates in an industry with high barriers to entry and stringent regulatory frameworks, which may provide a competitive moat against new entrants. Embecta's ability to navigate these challenges indicates a strong management team and the potential for long-term stability. The company's growth and market presence would largely depend on its approach to innovation, regulatory compliance, and adaptability to the evolving healthcare marketplace.
Stock Alerts - Embecta (EMBC)
 |
Embecta | January 10 Price is down by -5.2% in the last 24h. |
|
Embecta | January 7 Price is down by -5.2% in the last 24h. |
|
Embecta | December 24 Business Outlook among employees is down by 4.4% over the last month. |
|
Embecta | December 10 Web Traffic is down by 47.9% over the last month. |
Alternative Data for Embecta
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 41 | Sign up | Sign up | Sign up |
| Sentiment | 90 | Sign up | Sign up | Sign up |
| Webpage traffic | 35,000 | Sign up | Sign up | Sign up |
| Employee Rating | 62 | Sign up | Sign up | Sign up |
| Google Trends | 20 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 550 | Sign up | Sign up | Sign up |
| Facebook Followers | 29,287 | Sign up | Sign up | Sign up |
| Instagram Followers | 1,290 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 156 | Sign up | Sign up | Sign up |
| Twitter Followers | 1,126 | Sign up | Sign up | Sign up |
| Twitter Mentions | 8 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 496 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 40 | Sign up | Sign up | Sign up |
| Linkedin Employees | 1,167 | Sign up | Sign up | Sign up |
About Embecta
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes.
| Price | $17.93 |
| Target Price | Sign up |
| Volume | 325,250 |
| Market Cap | $1.07B |
| Year Range | $11.26 - $20.93 |
| Dividend Yield | 4.16% |
| PE Ratio | 13.7 |
| Analyst Rating | 33% buy |
| Earnings Date | February 6 '25 |
| Industry | Medical Devices |
In the news
 |
Inspire Investing LLC Trims Stake in Embecta Corp. (NASDAQ:EMBC)January 28 - ETF Daily News |
Embecta to Report Fiscal First Quarter 2025 Financial ResultsJanuary 23 - Finnhub |
|
 |
Comparing Embecta (NASDAQ:EMBC) and Steakholder Foods (OTCMKTS:MTTCF)January 21 - ETF Daily News |
 |
Embecta management to meet with BTIGJanuary 13 - Thefly.com |
 |
The Zacks Analyst Blog Highlights Doximity, BrightSpring Health Services and EmbectaJanuary 5 - Yahoo |
|
Geode Capital Management LLC Purchases 45,228 Shares of Embecta Corp. (NASDAQ:EMBC)December 29 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 282M | 220M | 174M | 15M | 26M | 0.450 |
| Q2 '24 | 273M | 168M | 190M | 15M | 66M | 0.740 |
| Q1 '24 | 287M | 194M | 185M | 29M | 82M | 0.670 |
| Q4 '23 | 276M | 184M | 186M | 20M | 51M | 0.610 |
| Q3 '23 | 278M | 208M | 182M | 6M | 44M | 0.590 |
Insider Transactions View All
| Melcher David F filed to buy 27,698 shares at $15.8. September 8 '23 |
| Elguicze Jacob filed to buy 66,027 shares at $21.7. August 10 '23 |
| Mann Jeffrey Z filed to buy 55,333 shares at $21.7. August 10 '23 |
| Kurdikar Devdatt filed to buy 244,791 shares at $21.8. August 10 '23 |
| Melcher David F filed to buy 21,465 shares at $32.5. February 15 '23 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Boston ScientificBSX |
$102.36 0% | 68 |
 |
Edwards LifesciencesEW |
$72.45 0% | 48 |
 |
Intuitive SurgicalISRG |
$571.88 0% | 79 |
 |
MedtronicMDT |
$90.82 0% | 43 |
 |
StrykerSYK |
$391.29 0% | 56 |
Read more about Embecta (EMBC) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Embecta?
The Market Cap of Embecta is $1.07B.
What is Embecta's PE Ratio?
As of today, Embecta's PE (Price to Earnings) ratio is 13.7.
When does Embecta report earnings?
Embecta will report its next earnings on February 6 '25.
What is the current stock price of Embecta?
Currently, the price of one share of Embecta stock is $17.93.
How can I analyze the EMBC stock price chart for investment decisions?
The EMBC stock price chart above provides a comprehensive visual representation of Embecta's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Embecta shares. Our platform offers an up-to-date EMBC stock price chart, along with technical data analysis and alternative data insights.
Does EMBC offer dividends to its shareholders?
Yes, Embecta (EMBC) offers dividends to its shareholders, with a dividend yield of 4.16%. This dividend yield represents Embecta's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Embecta in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Embecta?
Some of the similar stocks of Embecta are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.